Immunogenicity and safety of self-amplifying mRNA COVID-19 vaccine (ARCT-2303), with or without co-administration of seasonal inactivated influenza vaccine in adults: a phase 3, randomised, controlled, observer-blind, multicentre study.

ARCT-2303 - Arcturus Therap, CSL Behring

Kostaive (ARCT-154) - Arcturus Therap

DoCo-Pro-RBD-1+MF59 - The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Monash University

http://www.ncbi.nlm.nih.gov/pubmed/40896462

Carmen Baccarini; Carole Verhoeven; Charissa Tabora; Hongfan Jin; Igor Smolenov; Javier Cespedes Vargas; Josephine van Boxmeer; Judd L Walson; Leonela Barrientos; Matthew Hohenboken; May Emmeline Montellano; Michelle L Giles; Munro Neville; Paul Nguyen; Roberto Bugarini; Sachin Deshmukh; Xuexuan Liu

Sep 4, 2025